Rampart Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,002
| Closed | -$319K | – | 119 |
|
|
2020
Q3 | $319K | Sell |
4,002
-1,847
| -32% | -$147K | 0.2% | 118 |
|
|
2020
Q2 | $404K | Buy |
5,849
+647
| +12% | +$44.7K | 0.07% | 286 |
|
|
2020
Q1 | $327K | Sell |
5,202
-5,688
| -52% | -$358K | 0.16% | 135 |
|
|
2019
Q4 | $847K | Sell |
10,890
-147
| -1% | -$11.4K | 0.1% | 247 |
|
|
2019
Q3 | $809K | Sell |
11,037
-669
| -6% | -$49K | 0.1% | 244 |
|
|
2019
Q2 | $721K | Sell |
11,706
-735
| -6% | -$45.3K | 0.09% | 267 |
|
|
2019
Q1 | $793K | Buy |
12,441
+5,730
| +85% | +$365K | 0.09% | 261 |
|
|
2018
Q4 | $343K | Sell |
6,711
-5,019
| -43% | -$257K | 0.1% | 185 |
|
|
2018
Q3 | $681 | Sell |
11,730
-11,706
| -50% | -$680 | ﹤0.01% | 493 |
|
|
2018
Q2 | $1.14M | Buy |
23,436
+4,515
| +24% | +$219K | 0.11% | 251 |
|
|
2018
Q1 | $880K | Buy |
+18,921
| New | +$880K | 0.08% | 266 |
|
|
2017
Q4 | – | Sell |
-8,547
| Closed | -$311K | – | 505 |
|
|
2017
Q3 | $311K | Buy |
8,547
+312
| +4% | +$11.4K | 0.11% | 216 |
|
|
2017
Q2 | $325K | Buy |
+8,235
| New | +$325K | 0.12% | 197 |
|